Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
23
Recruiting, any sponsor type, condition "erectile dysfunction"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed276
23 trials
Showing 1 to 23, recently updated first.
- Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's DiseaseRecruiting
University Medical Center GroningenAcademic, hospital or other
NCT07903987 · 20 participants (planned) · Start Dec 13, 2024 · Primary completion Aug 30, 2027
Drug: 68Ga-FAPI (gallium-68-labeled fibroblast activation protein inhibitor) · For: Peyronie's Disease
Sites: Nieuwegein, Netherlands
- A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsPivotal-lookingRecruiting
Hanmi Pharmaceutical Company LimitedIndustry
NCT07899073 · 225 participants (planned) · Start Oct 2026 · Primary completion Sep 2027
Drug: HIP2602 + HPP2602-2; HPP2602-1 + HPP2602-2 and 1 more · For: Erectile Dysfunction
Sites: Busan, South Korea
Surgical Outcomes Research Centre (SOuRCe)Research network
NCT07576335 · 64 participants (planned) · Start Aug 31, 2026 · Primary completion Dec 1, 2028
Drug: Tadalafil 5 mg · For: Erectile Dysfunction Following Radical Prostatectomy; Prostate Cancer; Urinary Incontinence Following Surgical Procedure
Sites: Sydney, Australia · 3 sites in all
Mayo ClinicAcademic, hospital or other
NCT06065436 · 60 participants (planned) · Start Jan 19, 2024 · Primary completion Dec 2026
Drug: Collagenase Clostridium Histolyticum · For: Peyronie Disease; Erectile Dysfunction
Sites: Rochester, Minnesota
Beijing Inno Medicine Co., Ltd.Industry
NCT07311330 · 40 participants (planned) · Start Feb 4, 2026 · Primary completion Oct 2026
Drug: YN001 20mg Dose + 5% glucose injection · For: Atherosclerotic Cardiovascular Disease (ASCVD); Erectile Dysfunction
Sites: Beijing, China
- Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile DysfunctionPivotal-lookingRecruiting
Al-Azhar UniversityAcademic, hospital or other
NCT07753720 · 260 participants (planned) · Start Aug 13, 2026 · Primary completion Jun 30, 2027
Drug: Tadalafil; Current on-demand PDE5 inhibitor; Tadalafil 5 mg · For: Erectile Dysfunction; Tadalafil
Sites: Cairo, Egypt
Al-Azhar UniversityAcademic, hospital or other
NCT07773103 · 120 participants (planned) · Start Aug 19, 2026 · Primary completion Aug 2028
Drug: Tadalafil 5mg · For: Vasculogenic Erectile Dysfunction
Sites: Cairo, Egypt
Azienda USL Reggio Emilia - IRCCSGovernment (non-federal)
NCT07061145 · 350 participants (planned) · Start Jul 1, 2025 · Primary completion Dec 2026
Drug: Tirosin Kinase Inhibitors · For: Chronic Myelocytic Leukemia; Erectile Dysfunctions; CVD - Cardiovascular Disease and 1 more
Sites: Reggio Emilia, Italy
The Methodist Hospital Research InstituteAcademic, hospital or other
NCT07048314 · 40 participants (planned) · Start Jul 7, 2026 · Primary completion Jun 30, 2027
Drug: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office; Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR and 2 more · For: Erectile Dysfunction; Prostate Cancer
Sites: Houston, Texas
- L-Citrulline and Tadalafil for Mild to Moderate Erectile DysfunctionPivotal-lookingRecruiting
Beni-Suef UniversityAcademic, hospital or other
NCT07642505 · 133 participants (planned) · Start Jun 8, 2026 · Primary completion Nov 2026
Drug: L-Citrulline; Tadalafil and 2 more · For: Erectile Dysfunction
Sites: Banī Suwayf, Egypt
- A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile DysfunctionRecruiting
Ryan Flannigan, MDAcademic, hospital or other
NCT07601646 · 83 participants (planned) · Start May 2026 · Primary completion Apr 2027
Drug: ST-04 · For: Erectile Dysfunction (ED); Erectile Dysfunctions; Erectile Function
Sites: Vancouver, Canada
- Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile DysfunctionPivotal-lookingRecruiting
Ankara City Hospital BilkentAcademic, hospital or other
NCT07480161 · 90 participants (planned) · Start Dec 29, 2025 · Primary completion Dec 29, 2027
Drug: Umbilical Cord-Derived Mesenchymal Stem Cells; Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes and 1 more · For: Erectile Dysfunction With Diabetes Mellitus
Sites: Ankara, Turkey (Türkiye)
- TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in MenPivotal-lookingRecruiting
Lomonosov Moscow State University Medical Research and Educational CenterAcademic, hospital or other
NCT07460960 · 150 participants (planned) · Start Mar 5, 2026 · Primary completion Dec 2027
Drug: Pitavastatin 1-4 mg daily; Rosuvastatin 20-40 mg daily · For: Erectile Dysfunction Due to Arterial Disease; Atheroscleroses; Erectile Disfunction and 3 more
Sites: Moscow, Russia
- Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder PatientsPivotal-lookingRecruiting
Mansoura UniversityAcademic, hospital or other
NCT07391579 · 500 participants (planned) · Start Dec 1, 2025 · Primary completion Dec 2026
Drug: Tadalafil 5 mg & Sildenafil 100mg; Sildenafil 100mg & placebo · For: Erectile Dysfunctions
Sites: Al Mansurah, Egypt; Alexandria, Egypt; Aswān, Egypt · 11 sites in all
University of California, IrvineAcademic, hospital or other
NCT06720597 · 120 participants (planned) · Start Aug 13, 2025 · Primary completion Jan 2027
Drug: Daily low-dose PDE5 inhibitor therapy; Testosterone therapy as per clinical guidelines. · For: Erectile Dysfunction; Hypogonadism, Male; Endothelial Dysfunction
Sites: Newport Beach, California
- 4-aminopyridine Treatment for Nerve InjuryPivotal-lookingRecruiting
John ElfarAcademic, hospital or other
NCT03701581 · 70 participants (planned) · Start Jun 5, 2021 · Primary completion Jul 2027
Drug: 4-Aminopyridine · For: Nerve Injury; Prostate Cancer
Sites: Tucson, Arizona; Rochester, New York
Aspargo Labs, IncIndustry
NCT06872866 · 12 participants (planned) · Start Apr 15, 2025 · Primary completion Feb 28, 2026
Drug: ASP-001.1 · For: Erectile Dysfunction
Sites: New York, New York
Institute for the Study of Urological Diseases, GreeceAcademic, hospital or other
NCT07124871 · 30 participants (planned) · Start Jun 20, 2025 · Primary completion Feb 2026
Drug: PRP-derived exosomes injection · For: Erectile Dysfunction Due to Arterial Insufficiency
Sites: Thessaloniki, Greece
- Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of ProstatePivotal-lookingRecruiting
Mansoura UniversityAcademic, hospital or other
NCT05955001 · 110 participants (planned) · Start Apr 1, 2023 · Primary completion Jul 2025
Drug: Tadalafil 5mg / Placebo · For: Erectile Dysfunction; Lower Urinary Tract Symptoms
Sites: Al Mansurah, Egypt
- SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)Pivotal-lookingRecruiting
Icahn School of Medicine at Mount SinaiAcademic, hospital or other
NCT06945315 · 196 participants (planned) · Start Nov 14, 2023 · Primary completion Jul 14, 2027
Drug: SAFE (Saline assisted fascial engorgement) · For: Prostate Cancer; Erectile Dysfunction
Sites: New York, New York
- PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)Pivotal-lookingRecruiting
The Netherlands Cancer InstituteAcademic, hospital or other
NCT06875258 · 198 participants (planned) · Start Jan 15, 2024 · Primary completion Jan 1, 2027
Drug: Sildenafil · For: Erectile Dysfunction Following Radical Prostatectomy
Sites: Nijmegen, Netherlands; Amsterdam, Netherlands; Rotterdam, Netherlands
- Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile DysfunctionPivotal-lookingRecruiting
Aswan University HospitalAcademic, hospital or other
NCT06583590 · 32 participants (planned) · Start Aug 1, 2024 · Primary completion Aug 31, 2025
Drug: Botulinum toxin A; Tadalafil 5mg · For: Erectile Dysfunction With Diabetes Mellitus
Sites: Aswān, Egypt
Thomas Advanced Medical LLCIndustry
NCT04684602 · 5,000 participants (planned) · Start Jul 9, 2020 · Primary completion Jul 9, 2030
Drug: PrimePro™/ PrimeMSK™ · For: Autoimmune Diseases; Cardiovascular Disorders; Diabetes Complications and 8 more
Sites: Culver City, California
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.